| European Case Law Identifier: | ECLI:EP:BA:2013:T085209.20130906 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 06 September 2013 | ||||||||
| Case number: | T 0852/09 | ||||||||
| Application number: | 00918362.5 | ||||||||
| IPC class: | A61K 6/00 C12N 9/20 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Compositions and methods for effecting the levels of cholesterol | ||||||||
| Applicant name: | Aventis Pharmaceuticals Inc. The Trustees of The University of Pennsylvania |
||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - sufficiency of disclosure (no) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t090852eu1.html
Date retrieved: 17 May 2021